Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Sorin gets European rights to Respicardia's sleep apnea device, plus option to buy company

Executive Summary

Cardiovascular device firm Sorin Group SPA acquired exclusive rights to distribute Respicardia Inc.’s (implantable therapies to improve respiratory and cardiovascular health) remede neurostimulation system for central sleep apnea (CSA) in select European countries for five years.
Deal Industry
  • Medical Devices
    • Implantable Devices
Deal Status
  • Final
Deal Type
  • Alliance
    • Includes Equity
    • Marketing-Licensing

Related Companies

Advertisement
UsernamePublicRestriction

Register